CM
AUGX

Crystalline Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Crystalline Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$627K Buy
+266,614
New +$538K 0.56% 37

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Crystalline Management's AUGX Position: Q3 2024 in Review

Crystalline Management opened a new position in Augmedix, Inc. Common Stock (AUGX) in Q3 2024: 266,614 shares worth $627K. The stake represents 0.56% of the portfolio and ranks #37 among its holdings.

45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Crystalline Management held 266,614 shares of Augmedix, Inc. Common Stock worth $627K as of Q3 2024.
  • Augmedix, Inc. Common Stock was a new Crystalline Management position in Q3 2024.
  • Augmedix, Inc. Common Stock made up 0.56% of Crystalline Management's portfolio in Q3 2024, its #37 holding.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Crystalline Management's 13F filing for Q3 2024, filed 8 Nov 2024.